Imagine a simple switch in how we give kids pain relief could save thousands of pounds and significantly reduce our carbon footprint. Sounds too good to be true, right? But that’s exactly what a groundbreaking project in Swansea Bay has achieved. Led by five visionary clinicians, this initiative has uncovered a smarter way to administer paracetamol to young patients undergoing surgery—one that’s just as effective but far kinder to both the NHS budget and the planet. And this is the part most people miss: it’s not just about cost savings; it’s about a shift in mindset that could redefine how we approach healthcare sustainability.
Consultant Anaesthetists Tereza Soskova, Rebeca Harris, and Alex Morgan, alongside Senior Clinical Fellow Lara Sabry and Core Trainee doctor Linn Jarte, spearheaded the Improving Paracetamol use with Routine Oral over Venous administration (IMPROVE) project. Their focus? Comparing the traditional method of giving paracetamol intravenously (IV) to children under general anaesthetic with the simpler, oral approach—either in liquid or tablet form. The results were eye-opening.
Here’s where it gets controversial: While both methods provide identical pain relief, oral paracetamol is a clear winner in terms of cost and environmental impact. Oral administration costs mere pennies compared to the IV method, which is a staggering 24 times more expensive. Even more striking, IV paracetamol produces up to 12 times more carbon emissions. By avoiding IV paracetamol for planned paediatric surgeries, the project calculated that the NHS could save the equivalent environmental impact of driving over 23,000 miles annually. That’s a lot of emissions for a single medication.
Dr. Soskova explains, ‘There’s no difference in safety or pain relief between IV and oral paracetamol, but the cost and environmental savings are undeniable. We’re now aiming for a 90% oral usage rate in Swansea Bay.’ This shift alone could save thousands of kilograms of CO2 emissions each year—a small but significant step toward greener healthcare.
But here’s the bigger picture: Healthcare accounts for 5% of global greenhouse gas emissions, with pharmaceuticals contributing 19-32% of that total. Paracetamol, one of the world’s most commonly used medications, makes up 6% of all pharmaceutical sales. This project isn’t just about paracetamol; it’s a wake-up call to reevaluate how we deliver care. As Dr. Soskova notes, ‘We’re part of the problem, but we can also be part of the solution.’
The IMPROVE project is now expanding to adult surgeries across Morriston, Singleton, and Neath Port Talbot hospitals, where the potential for financial and environmental savings is even greater. With larger patient numbers, the impact could be transformative.
Here’s the thought-provoking question: If a simple change like this can make such a difference, what other untapped opportunities exist in healthcare to reduce costs and environmental harm? Are we doing enough to explore them? Let’s start the conversation—share your thoughts below. The future of sustainable healthcare might just depend on it.
